Sales & Marketing
Omnichannel didn’t fail biopharma. Our metrics did.
Omnichannel didn’t fail pharma. Our metrics did. In 2026, fixing that won’t be optional.
News
Sanofi gets double blow for MS drug tolebrutinib
Shares in Sanofi have slid on a double dose of bad news for its oral BTK inhibitor tolebrutinib, in development as a therapy for multiple sclerosis.
News
GSK closes on approval of asthma hope depemokimab
GSK is poised for the first major approval of depemokimab, a long-acting drug for severe asthma that can be dosed just twice a year.
News
CHMP decision levels the playing field for GSK's RSV jab
GSK's RSV vaccine is poised for EU approval in all adults aged 18 and over, bringing it into line with rival shots from Pfizer and Moderna.
News
UK teams up with Singapore on healthtech regulation
A partnership between medicines regulators in the UK and Singapore could allow patients in both countries to access new medical advances more quickly.
News
Press Releases
Views & Analysis
Editor's Picks
Editor's Picks
